Loading viewer...
earnings
Format: PDF earnings
Ambu reports Q2 and H1 2024/25 results with 15.4% organic revenue growth and 15.2% EBIT margin expansion. The company achieved a strong start for its Ambu® SureLight™ Connect launch in pulmonology and continued positive momentum in urology. Management confirms current FY 2024/25 financial guidance.
investor_presentation
13 Pages
earnings
50 Pages
Unknown
Singtel Q3 FY2017 Financial Results Presentation
earningsearnings
21 Pages
Singapore Telecommunications Limited
AES Corporation Q4 2022 Financial Review & Earnings
earningsearnings
49 Pages
The AES Corporation
Norwegian Air Shuttle Q3 2023 Earnings Presentation
earningsearnings
22 Pages
Norwegian Air Shuttle